Teva Pharmaceutical Industries

New ustekinumab biosimilar approvals for chronic inflammatory diseases, data supporting equivalent safety of etanercept and infliximab biosimilars, and significant cost savings with adalimumab biosimilar.

Teva Pharmaceuticals announced positive data from the SOLARIS trial, showing TEV-‘749 significantly improves social functioning and quality of life in schizophrenia patients. Safety profile aligns with oral olanzapine, with no new safety signals or PDSS events. Pharmacokinetic data supports TEV-‘749's efficacy. Presented at Psych Congress 2024.

US drug shortages decreased to 277 in Sept 2024, with 50% lasting 2+ years. Key shortages include ADHD meds, pain treatments, chemotherapy drugs, insulin, and diabetes/weight loss meds. IV fluids added due to Hurricane Helene impacting Baxter's production.

EU fined Teva Pharmaceutical Industries €463 million for spreading misleading info about Synthon's MS drug, delaying competition and driving up costs. Prices dropped 80% after Synthon's entry.

Alvotech and Teva announced FDA approval for a new 130 mg/26 mL (5 mg/mL) SELARSDI™ presentation, expanding its label to align with STELARA® indications. This allows for intravenous infusion and supports the U.S. launch in early 2025.

Teva fined €463M by EU antitrust enforcer for smear campaign against rival MS drug, misusing patent system to block market entry.

Teva fined 462.6 million euros by EU for abusing dominant position to delay competition to MS drug Copaxone; Teva plans to appeal.

Alvotech and Teva receive FDA clearance for Selarsdi (ustekinumab-aekn) 130 mg/26 ml, aligning its label with Stelara's indications in the U.S. prior to its 2025 launch. The approval follows successful biosimilar ustekinumab launches in Canada, Japan, and Europe, reflecting the companies' commitment to increasing access to biosimilars globally.

AION Labs launches ProPhet, an AI-driven startup focusing on identifying active small molecules for drug discovery, aiming to reduce time and cost by targeting challenging proteins.